Clinical Trial Update: Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of Gilotrif in advanced penile squamous cell carcinoma was terminated, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• Gilotrif (Afatinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Penile Squamous Cell Carcinoma (PSCC) | Phase 2 | Status: TERMINATED | Results posted: 2020-04-14